- Cord Blood America secures $7.5 million investment capital commitment from a health care fund
- To be drawn down through the sale of Series A Preferred Stock once a registration statement is filed and declared effective under the Securities Act of 1933
- Use of proceeds
- New stem cell initiatives
- Potential acquisitions
- Working capital needs
http://gaskinsco.com/linkto-cbai.shtml
No comments:
Post a Comment